Caribou Biosciences (CRBU) Non Operating Income (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Non Operating Income data on file, last reported at $1.2 million in Q1 2026.

• Non Operating Income for Q1 2026 came in at $1.2 million, down 59.1% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.1 million (down 113.15% YoY), and the FY2025 annual result was -$331000.0, down 101.89% from the prior year.
• Non Operating Income eased to $1.2 million in Q1 2026 per CRBU's latest filing, from $1.4 million in the prior quarter.
• Over five years, Non Operating Income peaked at $5.8 million in Q2 2024 and troughed at -$6.5 million in Q2 2025.
• A 5-year average of $2.3 million and a median of $3.1 million in 2023 frame the typical range for Non Operating Income.
• The sharpest annual moves came in 2022 and 2025: Non Operating Income jumped 10931.25% in 2022, then tumbled 212.34% in 2025.
• A 5-year view of Non Operating Income shows it stood at $3.7 million in 2022, then decreased by 14.46% to $3.1 million in 2023, then grew by 7.86% to $3.4 million in 2024, then slumped by 58.09% to $1.4 million in 2025, then retreated by 15.55% to $1.2 million in 2026.
• Business Quant data shows CRBU's Non Operating Income at $1.2 million in Q1 2026, $1.4 million in Q4 2025, and $1.9 million in Q3 2025.